Sputtr.com | Alternative Search Engine

Montelukast

Singulair (Montelukast Sodium)

SINGULAIR® (MONTELUKAST SODIUM) TABLETS, CHEWABLE TABLETS, AND ORAL GRANULES Singulair (Montelukast Sodium)

1-03 MT 108- Public AR- Art.46- Montelukast

Rapporteur's Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended 1-03 MT 108- Public AR- Art.46- Montelukast

Montair LC Tablets COMPOSITION

Montelukast sodium & Levocetirizine dihydrochloride tablets Montair LC Tablets COMPOSITION Each uncoated tablet contains: Montelukast sodium equivalent to Montelukast.....10 mg Levocetirizine dihydrochloride.....5 mg Excipients.....q.s. DOSAGE ...

Montelukast, a Leukotriene Receptor Antagonist, in ...

Montelukast, a Leukotriene Receptor Antagonist, in Combination With Loratadine, a Histamine Receptor Antagonist, in the Treatment of Chronic Asthma

Montelukast: More than a Cysteinyl Leukotriene Receptor ...

Mini-Review TheScientificWorldJOURNAL (2010) 10, 2403-2413 ISSN 1537-744X; DOI 10.1100/tsw.2010.229 *Corresponding author. ©2010 with author. Published by TheScientificWorld; www.thescientificworld.com 2403 Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?

MONTAIR LC COMPOSITION MONTAIR LC Tablets

Montelukast sodium & Levocetirizine dihydrochloride Tablets MONTAIR LC COMPOSITION MONTAIR LC Tablets Each uncoated tablet contains: Montelukast.....10 mg Levocetirizine dihydrochloride.....5 mg Excipients.....q.s. MONTAIR LC KID Tablets Each ...

Montelukast - UK Medicines Information

Page 2 of 6 MONTELUKAST Approved Name: Montelukast Brand Name (Manufacturer): Singulair ® Paediatric 4mg Chewable Tablet (Merck Sharpe & Dohme Ltd) Presentation: Chewable tablets containing 4.2mg montelukast sodium equivalent to 4mg montelukast BNF Therapeutic Class: Leukotriene receptor ...

Montelukast: its role in the treatment of childhood asthma ...

© 2007 Dove Medical Press Limited. All rights reserved Therapeutics and Clinical Risk Management 2007:3(5) 885–892 885 REVIEW Montelukast: its role in the treatment of

IN-PROCESS REVISION

Pharmacopeial Forum Vol. 36(1) [Jan. -Feb. 2010] IN-PROCESS REVISION 1 B RIEFING Mobile phase: See the gradient table below. Time Solution A Solution B Montelukast Sodium.

Sandoz Montelukast

This leaflet is part III of a three-part “Product Monograph” published when Sandoz Montelukast was approved for sale in Canada and is designed specifically for Con